*CANCELED* ACC.20 Together With World Congress of Cardiology (ACC.20/WCC)

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

InVera Infusion Device
Venous Intervention
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure on 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
The pilot study enrolled 10 patients with chronic venous disease (CEAP classification C2-C4) requiring ablation of the great saphenous vein (GSV) due to abnormal reflux, who were followed for one year.
The pilot study enrolled 10 patients with chronic venous disease (CEAP classification C2-C4) requiring ablation of the great saphenous vein (GSV) due to abnormal reflux, who were followed for one year.
The pilot study enrolled 10...
04/21/2026
Cath Lab Digest
BTK Intervention
Abbott Unveils Post-Approval Study Data Demonstrating Potential of Esprit BTK to Treat Significantly Sicker Patients with CLTI and Complex Lesions
04/21/2026
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the...
04/21/2026
Cath Lab Digest
imaging systems
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
04/21/2026
Conavi’s next-generation hybrid imaging system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. These technologies together enable physicians to visualize both deep vessel structures...
Conavi’s next-generation hybrid imaging system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. These technologies together enable physicians to visualize both deep vessel structures...
Conavi’s next-generation hybrid...
04/21/2026
Cath Lab Digest
Femoropopliteal Disease
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
04/21/2026
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif....
04/21/2026
Cath Lab Digest
Restenosis
UCLA Researchers Develop Smart Stent to Track Blood Flow in Real Time
04/17/2026
A UCLA team of bioengineers, computer scientists, and physicians designed a stent to be implanted during an angioplasty and powered by the natural pulsing of blood through the artery.
A UCLA team of bioengineers, computer scientists, and physicians designed a stent to be implanted during an angioplasty and powered by the natural pulsing of blood through the artery.
A UCLA team of bioengineers,...
04/17/2026
Cath Lab Digest
Reflow Medical Spur System
Peripheral Intervention
Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI
04/15/2026
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective,...
04/15/2026
Cath Lab Digest
Pulmonary Embolism
New STORM-PE Data Show Computer-Assisted Vacuum Thrombectomy With Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients 
04/13/2026
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM...
04/13/2026
Cath Lab Digest
Cook Medical’s Interventional iMRI Suite
MRI
Cook Medical and Siemens Healthineers Debut Integrated Interventional MRI Suite at SIR 2026
04/13/2026
iMRI enables a minimally invasive interventional practice ideal for precise soft tissue imaging, tumor targeting, biopsy and future ablation therapies, representing the future of radiation-free, image-guided care. 
iMRI enables a minimally invasive interventional practice ideal for precise soft tissue imaging, tumor targeting, biopsy and future ablation therapies, representing the future of radiation-free, image-guided care. 
iMRI enables a minimally...
04/13/2026
Cath Lab Digest
Percutaneous Ventricular Assist Device
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
04/08/2026
These milestones highlight what the next generation of temporary mechanical circulatory support can potentially enable; expanding access options, supporting mobility, and advancing how physicians manage critically ill patients.
These milestones highlight what the next generation of temporary mechanical circulatory support can potentially enable; expanding access options, supporting mobility, and advancing how physicians manage critically ill patients.
These milestones highlight what...
04/08/2026
Cath Lab Digest
From left to right - Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and Director of the Adams Valve Institute, David H. Adams, MD, the Marie-Josée and Henry R. Kravis Professor and Chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai and Cardiac Surgeon-in-Chief of the Mount Sinai Health System
Heart Valve Centers
Mount Sinai Launches Adams Valve Institute, Specializing in Complex Valve Surgery and Valvular Heart Disease
04/07/2026
“Our new Institute will expand our efforts across the full spectrum of valvular heart disease,” Dr. Adams says. “Collaboration has been the foundation of our success, bringing together cardiologists, imaging specialists, anesthesiologists,...
“Our new Institute will expand our efforts across the full spectrum of valvular heart disease,” Dr. Adams says. “Collaboration has been the foundation of our success, bringing together cardiologists, imaging specialists, anesthesiologists,...
“Our new Institute will expand...
04/07/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use